These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 18300604)

  • 21. Public health issues related to HPV vaccination.
    Hershey JH; Velez LF
    J Public Health Manag Pract; 2009; 15(5):384-92. PubMed ID: 19704306
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Natural history of human papillomavirus infections, cytologic and histologic abnormalities, and cancer.
    Wheeler CM
    Obstet Gynecol Clin North Am; 2008 Dec; 35(4):519-36; vii. PubMed ID: 19061814
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidemiology of mucosal human papillomavirus infection and associated diseases.
    Trottier H; Burchell AN
    Public Health Genomics; 2009; 12(5-6):291-307. PubMed ID: 19684442
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cervical cancer vaccination indications, efficacy, and side effects.
    Bayas JM; Costas L; Muñoz A
    Gynecol Oncol; 2008 Sep; 110(3 Suppl 2):S11-4. PubMed ID: 18586311
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Economic burden associated with the management of cervical cancer, cervical dysplasia and genital warts in Belgium.
    Annemans L; Rémy V; Lamure E; Spaepen E; Lamotte M; Muchada JP; Largeron N
    J Med Econ; 2008; 11(1):135-50. PubMed ID: 19450115
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevaccination distribution of human papillomavirus types in women attending at cervical cancer screening in Belgium.
    Arbyn M; Benoy I; Simoens C; Bogers J; Beutels P; Depuydt C
    Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):321-30. PubMed ID: 19124515
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human papillomavirus vaccines and anal carcinoma.
    Franceschi S; De Vuyst H
    Curr Opin HIV AIDS; 2009 Jan; 4(1):57-63. PubMed ID: 19339940
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human papillomavirus vaccines in HIV-positive men and women.
    De Vuyst H; Franceschi S
    Curr Opin Oncol; 2007 Sep; 19(5):470-5. PubMed ID: 17762573
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The incidence of genital warts in Australian women prior to the national vaccination program.
    Brotherton JM; Heywood A; Heley S
    Sex Health; 2009 Sep; 6(3):178-84. PubMed ID: 19653953
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human papillomavirus vaccines: an update for gynecologists.
    Ault KA
    Clin Obstet Gynecol; 2008 Sep; 51(3):527-32. PubMed ID: 18677145
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevention of cervical cancer: where immunology meets diagnostics.
    Meijer CJ; Heideman DA; Berkhof H; Snijders PJ
    Immunol Lett; 2009 Feb; 122(2):126-7. PubMed ID: 19100775
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Knowledge and attitudes about human papillomavirus (HPV) and HPV vaccines among women living in metropolitan and rural regions of China.
    Li J; Li LK; Ma JF; Wei LH; Niyazi M; Li CQ; Xu AD; Wang JB; Liang H; Belinson J; Qiao YL
    Vaccine; 2009 Feb; 27(8):1210-5. PubMed ID: 19135493
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human papillomavirus infection: the role of vaccination in pediatric patients.
    Nichols JR; Stovall SH; Jacobs RF
    Clin Pharmacol Ther; 2007 Apr; 81(4):607-10. PubMed ID: 17314926
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integration of human papillomavirus vaccination and cervical cancer screening in Latin America and the Caribbean.
    Franco EL; Tsu V; Herrero R; Lazcano-Ponce E; Hildesheim A; Muñoz N; Murillo R; Sánchez GI; Andrus JK
    Vaccine; 2008 Aug; 26 Suppl 11():L88-95. PubMed ID: 18945406
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Papillomavirus vaccine types 16 and 18: new drug. Cervical cancer: just another vaccine.
    Prescrire Int; 2008 Jun; 17(95):103-4. PubMed ID: 18623911
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prophylactic HPV vaccines: new interventions for cancer control.
    Barr E; Sings HL
    Vaccine; 2008 Nov; 26(49):6244-57. PubMed ID: 18694795
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acceptability of human papillomavirus vaccination among Chinese women: concerns and implications.
    Kwan TT; Chan KK; Yip AM; Tam KF; Cheung AN; Lo SS; Lee PW; Ngan HY
    BJOG; 2009 Mar; 116(4):501-10. PubMed ID: 19250361
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term clinical impact of introducing a human papillomavirus 16/18 AS04 adjuvant cervical cancer vaccine in Spain.
    Gauthier A; Martín-Escudero V; Moore L; Ferko N; de Sanjosé S; Pérez-Escolano I; Catalá-López F; Ferrer E; Bosch FX
    Eur J Public Health; 2008 Dec; 18(6):674-80. PubMed ID: 18641420
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reducing patient risk for human papillomavirus infection and cervical cancer.
    Herbert J; Coffin J
    J Am Osteopath Assoc; 2008 Feb; 108(2):65-70. PubMed ID: 18303060
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The utility of human papillomavirus testing in the management of atypical glandular cells on cytology.
    Sharpless KE; O'Sullivan DM; Schnatz PF
    J Low Genit Tract Dis; 2009 Apr; 13(2):72-8. PubMed ID: 19387126
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.